Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.

Source:http://linkedlifedata.com/resource/pubmed/id/2465302

Download in:

View as

General Info

PMID
2465302